Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
Neurology. 2012 Jan 24;78(4):269-78. doi: 10.1212/WNL.0b013e31824365e4. Epub 2012 Jan 11.
To identify copy number variant (CNV) causes of periventricular nodular heterotopia (PNH) in patients for whom FLNA sequencing is negative.
Screening of 35 patients from 33 pedigrees on an Affymetrix 6.0 microarray led to the identification of one individual bearing a CNV that disrupted FLNA. FLNA-disrupting CNVs were also isolated in 2 other individuals by multiplex ligation probe amplification. These 3 cases were further characterized by high-resolution oligo array comparative genomic hybridization (CGH), and the precise junctional breakpoints of the rearrangements were identified by PCR amplification and sequencing.
We report 3 cases of PNH caused by nonrecurrent genomic rearrangements that disrupt one copy of FLNA. The first individual carried a 113-kb deletion that removes all but the first exon of FLNA. A second patient harbored a complex rearrangement including a deletion of the 3' end of FLNA accompanied by a partial duplication event. A third patient bore a 39-kb deletion encompassing all of FLNA and the neighboring gene EMD. High-resolution oligo array CGH of the FLNA locus suggests distinct molecular mechanisms for each of these rearrangements, and implicates nearby low copy repeats in their pathogenesis.
These results demonstrate that FLNA is prone to pathogenic rearrangements, and highlight the importance of screening for CNVs in individuals with PNH lacking FLNA point mutations.
鉴定 FLNA 测序阴性的脑室周围结节性异位(PNH)患者的拷贝数变异(CNV)原因。
在 Affymetrix 6.0 微阵列上对来自 33 个家系的 35 名患者进行筛查,发现一名个体携带了破坏 FLNA 的 CNV。通过多重连接探针扩增还在另外 2 名个体中分离出 FLNA 破坏型 CNV。这 3 例进一步通过高分辨率寡核苷酸阵列比较基因组杂交(CGH)进行特征描述,通过 PCR 扩增和测序鉴定了重排的精确连接断点。
我们报告了 3 例由破坏 FLNA 一个拷贝的非重现性基因组重排引起的 PNH。第一个个体携带 113kb 的缺失,该缺失去除了 FLNA 的除第一个外显子以外的所有部分。第二个患者携带了一个复杂的重排,包括 FLNA 的 3' 端缺失以及部分重复事件。第三个患者携带了一个 39kb 的缺失,包含了所有的 FLNA 和相邻基因 EMD。FLNA 基因座的高分辨率寡核苷酸阵列 CGH 表明这些重排中的每一种都具有不同的分子机制,并暗示了附近的低拷贝重复在其发病机制中的作用。
这些结果表明 FLNA 容易发生致病性重排,并强调了在缺乏 FLNA 点突变的 PNH 患者中筛选 CNV 的重要性。